Next-Generation Radiological Technology

At Cairina, innovation drives our mission to transform personalized medicine. We’re expanding our platform to support cutting-edge therapies, monitor disease progression, and enhance imaging analysis.

Driving Innovation in Radiology

By broadening our focus to include more cancer types and clinical domains, we’re paving the way for smarter, more adaptable treatment solutions that empower clinicians and improve patient outcomes. Explore our vision for the future of precision care.

Disease Progression Monitoring

Cairina introduces advanced capabilities for tracking tumor progression and treatment response, empowering clinicians to make timely, informed decisions. By leveraging real-time insights into changes in tumor dynamics, the platform provides a clear picture of disease trajectories, improving long-term patient outcomes.

Anticipated Features

  • Real-Time Analytics: Continuously updates tumor behavior models for accurate progression tracking.

  • Predictive Insights: Anticipates disease changes using advanced algorithms.

  • Longitudinal Comparisons: Enables visualization of tumor evolution across multiple imaging sessions.

Enhanced Image Analysis Capabilities

Expanding its imaging modalities, Cairina will incorporate CT and PET scan data alongside its existing DCE-MRI analysis. This multimodal approach provides clinicians with a comprehensive view of the tumor environment, enhancing diagnostic accuracy and treatment planning.

Anticipated Features

  • Multimodal Imaging Integration: Supports CT, PET, and DCE-MRI for a holistic tumor assessment.

  • Improved Data Resolution: Combines imaging modalities for higher precision in identifying tumor boundaries and characteristics.

  • Seamless Workflow Compatibility: Integrates effortlessly into current clinical workflows, saving time and reducing complexity.

New Disease Modeling

Cairina is expanding its applications beyond oncology to model fluid dynamics in other clinical domains, such as lymphedema. The platform also plans to support a broader range of cancers, including breast, pancreatic, prostate, and ovarian, addressing critical gaps in personalized treatment planning for these diseases.

Anticipated Features

  • Fluid Flow Modeling Across Domains: Applies proprietary algorithms to conditions like lymphedema.

  • Broad Cancer Application: Adds modeling support for breast, pancreatic, prostate, and ovarian cancers.

  • Adaptive Framework: Easily scales to new disease areas with minimal adjustment to core technology.